BTG3 and COVID-19: In contrast, the overall ANA positivity rate in COVID-19 serum samples in this study was 6.4%, with a positivity rate of only 3.2% in severe and critical cases, differing from previous ANA detection rates in patients with COVID-19 (4, 5).